Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-11

Clinical Trial Update: Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis [NA]

View source ↗

Summary

A terminated clinical trial assessing radiofrequency ablation as a treatment for amiodarone-induced thyrotoxicosis; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: Mayo Clinic | Conditions: Amiodarone-Induced Thyrotoxicosis | NA | Status: TERMINATED | Results posted: 2021-10-11